共 11 条
[1]
Cardiovascular safety of vardenafil, a potent, highly selective PDE-5 inhibitor in patients with erectile dysfunction: an analysis of five placebo-controlled clinical trials. Kloner RA,Mohan P,Norenberg C,et al. Pharmacotherapy . 2002
[2]
Global perspectives and controversies in the epidemiology of male erectile dysfunction. Nehra A,Kulaksizoglu H. Current Opinion in Urology . 2002
[3]
Exercise-induced ischemia was not adversely affected by vardenafil during an exercise stress test in men with coronary artery disease. Thadani U,Mazzu A. European Urology . 2002
[4]
Vardenafil improved patient satisfaction with erection hardness, orgasmic function, and sexual experience in men with erectile dysfunction. Donatucci C,Pommerville P,Niederberger C,et al. Journal d Urologie . 2003
[5]
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Goldstein I,Young JM,Fishcher J,et al. Diabetes Care . 2003
[6]
Vardenafil restores normal functioning to men with erectile dysfunction. Padma-Nathan H,Eardley I,Collins O,et al. Journal d Urologie . 2002
[7]
Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erecitle dysfunction. Stief C,Porst H,Saenz de Tejada I,et al. International Journal of Clinical Practice . 2004
[8]
Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Valiquette L,Hellstrom W,Gittelman M. International Journal of Impotence Research . 2002
[9]
Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. Hellstrom WJ,Gittelman M,Karlin G,et al. Journal of Andrology . 2002
[10]
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction:the first at-home clinical trail. Porst H,Rosen R,Padma-Nathan H,et al. International Journal of Impotence Research . 2001